2 Bellwethers Selected Against Lilly In Testosterone MDL

Law360, New York (June 22, 2017, 5:32 PM EDT) -- The Illinois federal judge overseeing multidistrict litigation against manufacturers of testosterone replacement therapy drugs on Thursday selected the first two cases that will go to trial against Eli Lilly and Co.

U.S. District Judge Matthew F. Kennelly chose for trial Tracy Garner's and John DeBroka Jr.’s cases alleging that Eli Lilly’s Axiron caused them to suffer from a heart attack and deep vein thrombosis respectively.

A schedule filed on the docket in October indicates that the cases will be heard in January and March 2018, though neither Eli Lilly nor a member of the Plaintiff’s Steering Committee was immediately available to...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!